Product Information
- 1-Phenanthrenecarboxylic acid, dodecahydro-1,4a-dimethyl-7-(1-methylethyl)-, methyl ester
- Abietic acid, dihydro-, methyl ester
- Dihydroabietic acid methyl ester
- Methyl (8Xi)-Abiet-13-En-18-Oate
- Methyl dihydroabietate
Methyl Dihydroabietate is a matrix metalloproteinase inhibitor that can be used for the treatment of osteoarthritis. It inhibits the activity of matrix metalloproteinases and, therefore, prevents the degradation of cartilage. Methyl Dihydroabietate has synergistic effects with levopimaric acid, a divalent hydrocarbon that inhibits the production of prostaglandins. This combination leads to increased viscosity and inhibition of cartilage degradation. Methyl Dihydroabietate also inhibits fatty acid oxidation products such as hydrogenated and nonpolar solvent compounds. These inhibitory effects on lipid oxidation may reduce inflammation in joints by decreasing free radicals and reactive oxygen species.
Chemical properties
Technical inquiry about: 3D-FBA96845 Methyl Dihydroabietate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
